TLR4 and esophageal disorder: Furthermore, advances in glycoengineering could enable the manipulation of LPS structures, offering new potential therapeutic strategies such as engineered probiotics or synthetic glycans to modulate TLR4 signaling and restore immune balance in these esophageal disorders.